MedKoo Cat#: 414895 | Name: PGN-9856
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PGN-9856 is a novel potent, selective prostaglandin EP2 receptor agonist. PGN-9856 exhibits high affinity for the EP₂ receptor, with a pKᵢ value of 8.6, and demonstrates full agonist activity, achieving a pEC₅₀ of 8.4 in functional assays. Notably, PGN-9856 shows exceptional selectivity, displaying minimal activity at other prostanoid receptors, including EP₄, and across a range of 45 receptors, 4 ion channels, 2 transporters, and 2 kinases. In vivo studies have highlighted PGN-9856's potent ocular hypotensive effects. Its isopropyl ester prodrug, JV-GL1, significantly reduces intraocular pressure (IOP) in Cynomolgus monkeys, with a single dose maintaining lowered IOP for an unprecedented duration of 5 to 10 days.

Chemical Structure

PGN-9856
PGN-9856
CAS#863704-91-0

Theoretical Analysis

MedKoo Cat#: 414895

Name: PGN-9856

CAS#: 863704-91-0

Chemical Formula: C21H15F2NO4

Exact Mass: 383.0969

Molecular Weight: 383.35

Elemental Analysis: C, 65.80; H, 3.94; F, 9.91; N, 3.65; O, 16.69

Price and Availability

Size Price Availability Quantity
25mg USD 350.00 2 Weeks
50mg USD 550.00 2 Weeks
100mg USD 950.00 2 Weeks
1g USD 4,250.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
PGN-9856; PGN9856; PGN 9856
IUPAC/Chemical Name
2-(3-(((3',4-Difluoro(1,1'-biphenyl)-3-yl)carbonyl)amino)phenoxy)acetic acid
InChi Key
HZJWJNHYKNSGAT-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H15F2NO4/c22-15-4-1-3-13(9-15)14-7-8-19(23)18(10-14)21(27)24-16-5-2-6-17(11-16)28-12-20(25)26/h1-11H,12H2,(H,24,27)(H,25,26)
SMILES Code
O=C(O)COC1=CC=CC(NC(C2=CC(C3=CC=CC(F)=C3)=CC=C2F)=O)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 383.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Woodward DF, Coleman RA, Woodrooffe AJ, Spada CS, Wang JW. Effect of the Antiglaucoma Agent JV-GL1 and Related Compounds in the Canine Eye. J Ocul Pharmacol Ther. 2020 Oct;36(8):636-648. doi: 10.1089/jop.2020.0033. Epub 2020 Jul 8. PMID: 32640926. 2: Coleman RA, Woodrooffe AJ, Clark KL, Toris CB, Fan S, Wang JW, Woodward DF. The affinity, intrinsic activity and selectivity of a structurally novel EP2 receptor agonist at human prostanoid receptors. Br J Pharmacol. 2019 Mar;176(5):687-698. doi: 10.1111/bph.14525. Epub 2019 Jan 4. PMID: 30341781; PMCID: PMC6365485. 3: Woodward DF, Wang JW, Coleman RA, Woodrooffe AJ, Clark KL, Stamer WD, Tao G, Fan S, Toris CB. A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method. J Ocul Pharmacol Ther. 2019 Jun;35(5):265-277. doi: 10.1089/jop.2018.0126. Epub 2019 Apr 25. PMID: 31025909. 4: Miller PE, Eaton JS. Medical anti-glaucoma therapy: Beyond the drop. Vet Ophthalmol. 2021 Mar;24 Suppl 1:2-15. doi: 10.1111/vop.12843. Epub 2020 Nov 9. PMID: 33164328.